Sex-related Differences in Mast Cell Activity and Doxorubicin Toxicity:A Study in Spontaneously Hypertensive Rats

Toxicologic Pathology

Volumn 42, Issue 2, 2014, Pages 361-375

  Zhang, Jun ^a   Knapton, Alan ^a   Lipshultz, Steven E ^b   Cochran, Thomas R ^a   Hiraragi, Hajime ^c   Herman, Eugene H ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c AMGEN INC   (United States)

Author keywords

cardiac mast cells; cardiomyopathy; doxorubicin; nephropathy; ovariectomy; renal mast cells; spontaneously hypertensive rats

Indexed keywords

CARDIAC MAST CELLS; CARDIOMYOPATHY; DOXORUBICIN; NEPHROPATHY; OVARIECTOMY; RENAL MAST CELLS.; SPONTANEOUSLY HYPERTENSIVE RATS;

ANIMALS; BLOOD CHEMICAL ANALYSIS; CARDIOMYOPATHIES; DOXORUBICIN; FEMALE; HEART; KIDNEY; KIDNEY DISEASES; MALE; MAST CELLS; OVARIECTOMY; RATS; RATS, INBRED SHR; SEX FACTORS;

ALBUMIN; CHOLESTEROL; DOXORUBICIN; TRIACYLGLYCEROL; TROPONIN T;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEART MUSCLE INJURY; MALE; MAST CELL; MAST CELL DEGRANULATION; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; SPONTANEOUSLY HYPERTENSIVE RAT; TREATMENT DURATION; WEIGHT GAIN;

EID: 84886015801     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623313482778     Document Type: Article

References (45)

1. Billingham M. E. (1991). Role of endomyocardial biopsy in the diagnosis and treatment of heart disease. In Cardiovascular Pathology (Silver M. D., ed.), pp. 1465–86. Churchill Livingstone, New York, NY.
2. Borras C. Sastre J. Garcia-Sala D. Lloret A. Pallardo F. V. Vina J. (2003). Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. Free Radic Biol Med 34, 546–52.
3. Cortes E. P. Lutman G. Wanta J. Pickren J. Wallace J. Holland J. (1975). Adriamycin (NSC 123127) cardiotoxicity. A clinicopathologic correlation. Cancer Chemother Rep Part 3, 215–25.
4. Ehara T. Shigematsu H. (2003). Mast cells in the kidney. Nephrol 8, 130–8.
5. Estensen R. D. (1985). What is the role of myocardial mast cells? Hum Pathol 17, 536–8.
6. Frisancho-Kiss S. Davis S. E. Nyland J. F. Frisancho J. A. (2007). Cutting edge: Cross-regulation by TLR4 and T cell Ig mucin-3 determines sex differences in inflammatory heart disease. J Immunol 178, 6710–14.
7. Ha B. J. (2004). Oxidative stress in ovariectomized menopause and role of chondroitin sulfate. Arch Pharm Res 27, 867–72.
8. Hellstrom B. Holmgren H. H. (1950). Numerical distribution of mast cells in the human skin and heart. Acta Anat (Basel) 10, 81–107.
9. Herman E. H. El Hage A. Ferrans V. J. Ardalan B. (1985). Comparison of the severity of the chronic cardiotoxicity produced by doxorubicin in normotensive and hypertensive rats. Toxicol Appl Pharmacol 78, 202–14.
10. Herman E. H. Zhang J. Takeda K. Yu Z-X. Ferrans V. J. (1999). Correlation between serum levels of cardiac troponin T and the severity of the chronic cardiomyopathy induced by doxorubicin. J Clin Oncol 17, 2237–43.
11. R.R.M., Julicher, L., Steerenberg, G.R., Haenen, A., Bast, J., Noordhoek, Sex differences in the cellular defence system against free radicals from oxygen or drug metabolites in rat, Arch Toxicol, (1984), 56, 83-86
12. R.R.M., Julicher, L., Steerenberg, G.R., Haenen, A., Bast, J., Noordhoek, The effect of chronic adriamycin treatment on heart, kidney and liver tissue of male and female rat, Arch Toxicol, (1988), 61, 275-281
13. Knapton A. D. Zhang J. Sistare F. D. Hanig J. P. (2010). The use of in situ perfusion of the rat mesentery as a model to investigate vascular injury directly induced by drugs. Methods Find Exp Clin Pharmacol 32, 489–97.
14. Krischer J. P. Epstein S. Cuthbertson D. D. Goorin A. M. Epstein M. L. Lipshultz S. E. (1997). Clinical cardiotoxicity following anthracycline treatment for childhood cancer: The pediatric oncology group experience. J Clin Oncol 15, 1544–52.
15. Levick S. P. Melendez G. C. Plante E. McLarty J. L. Brower G. L. Janicki J. S. (2011). Cardiac mast cells: The centerpiece in adverse myocardial remodeling. Cardiovasc Res 89, 12–19.
16. Lipshultz S. E. Lipsitz S. R. Mone S. M. Goorin A. M. Sallen S. E. Sanders S. P. Orav E. J. Gelber R. D. Culan S. D. (1995). Female sex and dose as a risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. N Engl J Med 332, 1730–33.
17. Lipshultz S. E. Lipsitz S. R. Sallen S. E. Dalton V. M. Mone S. M. Gelber R. D. (2005). Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. J Clin Oncol 23, 2629–36.
18. Lipshultz S. E. Scully R. E. Lipsitz S. R. Sallan S. E. Silverman L. B. Miller T. L. Barry E.V. Asselin B. L. Athale U. Clavell L. A. Larsen E. Moghrabi A. Samson Y. Michon B. Schorin M. A. Cohen H. J. Neuberg D. S. Orav E. J. Colan S. (2010). Assessment of dexrazoxane as a cardioprotectant in doxorubicin treated children with high risk acute lymphoblastic leukemia: Long-term follow-up of a prospective, randomized, multicentre trial. Lancet Oncol 11, 950–61.
19. Lu H. Melendez G. C. Levick S. P. Janicki J. S. (2012). Prevention of adverse cardiac remodeling to volume overload in female rats is the result of an estrogen-altered mast cell phenotype. Am J Physiol Heart Circ Physiol 302, H811–17.
20. Mack M. Rosenkranz A. R. (2009). Basophils and mast cells in renal injury. Kidney Int 76, 1142–47.
21. Montilla P. Tunez M. C. Delgado M. J. Salcedo M. (2000). Hyperlipidemic nephropathy induced by Adriamycin in ovariectomized rats. Role of free radicals and effect of 17 beta-estradiol administration. Nephron 85, 65–70.
22. Mori T. Kai H. Kajimoto H. Koga M. Kudo H. Takayama N. Yasuoka S. Anegawa T. Kai M. Imaizum T. (2011). Enhanced cardiac inflammation and fibrosis in ovariectomized hypertensive rats: A possible mechanism of diastotic dysfunction in postmenopausal women. Hyperten Res 34, 496–502.
23. Munoz-Castaneda B. J. Tunez I. Munoz M. C. Bujalance I. Muntane J. Montilla P. (2005). Effects of catecholestrogen administration during adriamycin-induced cardiomyopathy in ovariectomized rat. Free Radical Research 39, 943–48.
24. Munoz-Castaneda J. F. Mutane J. Herencia C. Munoz M. C. Bujalance I. Montilla P. Tunez I. (2006). Ovariectomy exacerbates oxidative stress and cardiomyopathy induced by Adriamycin. Gynecol Endocrinol 22, 74–79.
25. Munoz-Castaneda J. R. Montilla P. Munoz M. C. Bujalance I. Muntane J. Tunez I. (2005). Effect of 17-β-estradiol administration during induced cardiomyopathy in ovariectomized rat. Eur J Pharmacol 523, 86–92.
26. Munoz-Castaneda J. R. Muntane J. Munoz M. C. Bujalance I. Montilla P. Tunez I. (2005). Estradiol and catecholestrogens protect against adriamycin-induced oxidative stress in erythrocytes of ovariectomized rats. Toxicol Lett 160, 196–203.
27. Nakano N. Nishiyama C. Yagita H. Koyanagi A. Akiba H. Chiba S. Ogawa H. Okumura K. (2009). Notch signaling confers antigen-presenting cell function on mast cells. J Allergy Clin Immunol 123, 74–81.
28. NRC (National Research Council). (1996). Guide for the Care and Use of Laboratory Animals, pp. 227–33. National Academy Press, Washington, DC.
29. Oge A. Sezer E. D. Ozgonul M. Bayraktar F. Sozmen E. Y. (2003). The effects of estrogen and raloxifene treatment on the antioxidant enzymes and nitrite-nitrate levels in brain cortex of ovariectomized rats. Neurosci Lett 338, 217–20.
30. Ogita H. Node K. Kitakaze M. (2003). The role of estrogen and estrogen-related drugs in cardiovascular diseases. Urr Drug Metab 4, 497–504.
31. Ozgonul M. Pge A. Sezer E. D. Bayraktar F. Sozmen E. Y. (2003). The effects of estrogen and raloxifene treatment on antioxidant enzymes in brain and liver of ovariectomized female rats. Endocr Res 29, 183–89.
32. Rakusan K. Sarkar K. Turek Z. Wicker P. (1990). Mast cells in the rat heart during normal growth and in cardiac hypertrophy. Cir Res 66, 511–16.
33. Sakemi T. Ohtsuka N. Tomiyoshi Y. Morito F. (1996). Sex difference in progression of adriamycin-induced nephropathy in rats. Am J Nephrol 16, 540–47.
34. Sakemi T. Ohtsuka N. Tomiyoshi Y. Morito F. (1997). The ovaries attenuate the aggravating effect of testosterone on glomerular injury in Adriamycin-induced nephropathy of female rats. Kidney Blood Press Res 20, 44–50.
35. Sartori-Valinotti J. C. Iliescu R. Fortepiani L. A. Yaues L. L. Reckelhoff J. F. (2007). Sex differences in oxidative stress and the impact of blood pressure control and cardiovascular disease. Clin Exp Pharmacol Physiol 34, 938–45.
36. Satoh M. Matter C. M. Ogita H. Takeshita K. Wang C. Y. Dorn G. W. 2nd Liao J. K. (2007). Inhibition of apoptosis-regulated signaling kinase-1 and prevention of congestive heart failure by estrogen. Circulation 115, 3197–204.
37. Shiota N. Rysa J. Kovanen P. T. Ruskoaho H. Kokkonen J. O. Lindstedt K. A. (2003). A role for cardiac mast cells in the pathogenesis of hypertensive heart disease. J Hypertens 21, 1935–44.
38. Van Hoesel Q. G. Steerenberg P. A. Dormans J. A. deJong W. H. deWildt D. J. Vos J. G. (1986). Time-course study on doxorubicin-induced nephropathy and cardiomyopathy in male and female Lou/M/Wsl rats: Lack of evidence for a causal relationship. J Nat cancer Inst 76, 299–307.
39. Van Hoesel Q. G. Steerenberg P. A. Vos J. G. Hillen F. C. Dormans J. A. (1984). Antitumor effect, cardiotoxicity and nephrotoxicity of doxorubicin in the IgM solid immunocytoma-bearing Lou/M/Wsl rat. J Nat cancer Inst 72, 1141–50.
40. Von Hoff D. D. Layard M. W. Basa P. Davis H. L. Jr Von Hoff A. L. Rozencweig M. Muggia F. M. (1979). Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 91, 710–17.
41. Webster-Gandy J. Warren J. Henry C. J. (2003). Sexual dimorphism in fat patterning in a sample of 5 to 7 year old children in Oxford. Int J Food Sci Nutr 54, 467–71.
42. Zhang J. Clark J. R. Jr Herman E. H. Ferrans V. J. (1996). Doxorubicin-induced apoptosis in spontaneously hypertensive rats: Differential effects in heart, kidney and intestine and inhibition by ICRF-187. J Mol Cell Cardiol 28, 1931–43.
43. Zhang J. Herman E. H. Ferrans V. J. (1993). Dendritic cells in the heart of spontaneously hypertensive rats treated with doxorubicin with or without ICRF-87. Am J Pathol 142, 1916–26.
44. Zhang J. Herman E. H. Ferrans V. J. (1994). Effects of ICRF-186 [(L)1,2-bis(3,5-ioxopiperazinyl-1-yl)propanel] on the toxicity of doxorubicin in spontaneously hypertensive rats. Toxicology 92, 179–92.
45. Zhang J. Yu Z.-X. Fujita S. Yamaguchi M. L. Ferrans V. J. (1993). Interstitial dendritic cells of the rat heart: Quantitative and ultrastructural changes in experimental myocardial infarction. Circulation 87, 909–20.